McCarthy Christopher bought IDXG
August 20, 2026 · Form 4 insider transaction
McCarthy Christopher bought 554,018 shares of Interpace Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
554,018
Price
$0.00
Total value
N/A
InsiderMcCarthy Christopher
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after554,018
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc.; On August 20, 2026, the Reporting Person was granted 554,018 RSUs, of which 277,009 vested upon grant and 277,009 will vest on August 20, 2027, subject to the Reporting Person's continued service on such vesting date.